Research Areas

Our faculty's research diversity has resulted in numerous collaborations among principal investigators as they discover common themes and approaches within their research programs. The faculty has also excelled in transferring its research technology to the marketplace. Many of UAlberta's spin-off companies originated in the Faculty of Pharmacy and Pharmaceutical Sciences.

Research has always been the strength of the faculty. We have one of the largest faculties of pharmacy in Canada that excels in transferring its research to the marketplace. Our academic staff’s research interests are of the most diverse on campus.

Pharmacy Practice

Clinical

Patient oriented research conducted with human subjects; it includes mechanisms of human disease, therapeutic interventions, clinical trials, development of new technologies (National Institute of Heath).

Researchers: Dr. Jill Hall, Dr. Christine Hughes, Dr. Sherif Mahmoud & Dr. Nese Yuksel

Education

A field of inquiry aimed at advancing knowledge of education and learning processes and development of the tools and methods necessary to support this endeavor.(American Educational Research Association).

Researchers: Dr. Ken Cor, Dr. Neal Davies, Dr. Lisa Guirguis, Dr. Cheryl Sadowski & Dr. Scot Simpson

Health Services

Improving the way health care services are organized, regulated, managed, financed, paid for, used and delivered, in the interest of improving the health and quality of life of all Canadians (CIHR).

Researchers:Dr. Mark Makowsky, Dr. Cheryl Sadowski, Dr. Scot Simpson & Dr. Nese Yuksel

Knowledge Translation

Using knowledge obtained from research to inform the decision making of healthcare professionals and improve outcomes (CIHR).

Researchers: Dr. Sherif Mahmoud & Dr. Mark Makowsky

Pharmacoepidemiology

Provides an estimate of the probability of beneficial effects of a drug in a population and the probability of adverse effects (John Hopkins University).

Researchers: Dr. Jill Hall & Dr. Scot Simpson

Pharmacy Practice

Focuses on the assessment and evaluation of pharmacy practice. It includes studies that evaluate pharmacists' roles in a variety of capacities (CPhA).

Researchers:Dr. René Breault, Dr. Lisa Guirguis & Dr. Terri Schindel

Social Administrative

The "people" aspect of pharmacy and medication use. Focusing on the scientific and humanistic bases for understanding and influencing interactions involving patients, medicines, caregivers, and health care systems (University of Wisconsin).

Researchers: Dr. Lisa Guirguis & Dr. Terri Schindel


Pharmaceutical Sciences

Cardiovascular

Researchers: Dr. Fakhreddin Jamali, Dr. Paul Jurasz , Dr. John Seubert , Dr. John Ussher, Dr. Dion Brocks & Dr. Khaled Barakat

Computational Drug Discovery

Researchers: Dr. Khaled Barakat

Drug Delivery

A field that concentrates on formulation methods and technologies that are employed to transport pharmaceutical compounds to various sites in the body. It may include synthetic drug carrier systems capable of improving the bioavailability and/or tissue-specific targeting of an active pharmaceutical ingredient (API) to the site of desired drug action, such as bone drug delivery, or drug targeting of cancer cells.

Researchers: Dr. Neal Davies, Dr. Michael Doschak, Dr. Afsaneh Lavasanifar & Dr. Raimar Löbenberg

Medical Chemistry

Researchers: Dr. Carlos Velázquez & Dr. Khaled Barakat

Neurology/Critical Care

Research in this area aims for improving outcomes in patients with neurological emergencies (subarachnoid hemorrhage, intracerebral hemorrhage, ischemic stroke, traumatic brain injury and status epilepticus) and patients with epilepsy through pharmacotherapy optimization of existing therapies and translation of new treatments.

Researchers: Dr. Sherif Mahmoud

Obesity/Type 2 Diabetes

Researchers: Dr. John Ussher

Pharmacodynamics

Studies what a drug does to the body. Drug effect involves receptor binding, post-receptor effects, and biochemical interactions. It is a drug's pharmacokinetics that determines the onset, duration, and intensity of a drug's effect. 

Researchers: Dr. Dion Brocks, Dr. Tony Kiang, Dr. Sherif MahmoudDr. Patrick Mayo

Pharmacogenetics

Studies how variation in one single gene influences the response to a single drug.

Researchers: Dr. Dion BrocksDr. Tony KiangDr. Sherif Mahmoud & Dr. Patrick Mayo

Pharmacogenomics

Studies how all the genes that comprise the genome can influence drug responses through pharmacokinetic and pharmacodynamics mediated effects.

Researchers: Dr. Patrick Mayo & Dr. Tony Kiang

Pharmacokinetics

Studies what the body does to a drug. This field deals with the movement of a drug over time into, through, and out of the body via the processes of absorption, distribution, metabolism, excretion, and transport.

Researchers: Dr. Dion Brocks, Dr. Neal Davies, Dr. Fakhreddin Jamali, Dr. Tony Kiang, Dr. Sherif Mahmoud & Dr. Patrick Mayo

Pharmacometrics

An emerging science that quantifies drug, disease, and clinical trial information for drug development. Originally focusing on concentration-effect, does-effect, and PKPD relationships. It has expanded to develop disease models and quantitative relationships between biomarkers and clinical response.

Researchers: Dr. Patrick Mayo, Dr. Dion Brocks & Dr. Tony Kiang

Pharmacology & Toxicology

Researchers: Dr. Khaled Barakat, Dr. Ayman El-Kadi, Dr. Fakhreddin Jamali, Dr. Tony Kiang, Dr. John Seubert & Dr. Arno Siraki

Translational Pharmacology

Researchers: Dr. Tony Kiang